经皮经肝胆管穿刺内支架植入治疗恶性梗阻性黄疸的临床价值  

Clinical value of percutaneous transhepatic biliary stent implantation in malignant obstructive jaundice

作　　者：易玉海[1] 金鹏[1] 李凡东[1] 谢志勇[1] 刘训伟[1] 张绪平[1] 

机构地区：[1]济南军区总医院医学影像科,250031

出　　处：《中华消化病与影像杂志（电子版）》2012年第5期20-22,共3页Chinese Journal of Digestion and Medical Imageology(Electronic Edition)

摘　　要：目的探讨经皮经肝胆管穿刺内支架植入治疗恶性梗阻性黄疸的临床应用价值。方法济南军区总医院1996年10月至2011年12月收治恶性梗阻性黄疸患者208例,均采用X线透视下经皮经肝穿刺胆道内支架植入术治疗,根据梗阻部位的不同决定放置支架的方式。结果 208例患者中,190例植入单支支架于肝总管或(和)胆总管,7例植入2支以上支架于总管和分支胆管,11例行外引流。全部患者治疗后2周内血清胆红素从(436±314)mol/L降低到(53±31)mol/L。结论经皮经肝胆管穿刺内支架植入是治疗恶性梗阻性黄疸的有效方法。Objective To evaluate the clinical application of percutaneous transhepatic biliary stent implantation in malignant obstructive jaundice. Methods Two hundred and eight patients with malignant obstruction jaundice in Jinan Military General Hospital from October 1996 to December 2011 were treated by pereutaneous transhepatic biliary stent implantation under fluoroscopy. The ways of stent implantation were based on the location of obstructive. Results In 238 patients, single stem was implanted in the common hepatic duct or （and） the common bile duct in 190 patients. 2 or more stents were implanted in the common duct and its branches in 7 patients. 11 of them were done by extra-drainage. The sermn bilirubin levels in all patients were remarkably declined from （436 ±314） mol/L to （53 ± 31 ） mol/L in 2 weeks after treatment. Conclusions Percutaneous transhepatic biliary stent inaplantation is an effective therapy for malignant biliary obstruction.

关 键 词：介入放射学 胆道支架 胆道梗阻 

分 类 号：R735[医药卫生—肿瘤]